Editors/Authors   Librarians   Newsletter   Site Tour   Subscriptions   A-Z Index   About   Contact Us   Help 
Log In | Log In via Athens
 
Disable Autosuggest
Users' Guides to the Medical Literature
Guyatt G, Rennie D, Meade MO, Cook DJ
Part F Summarizing the Evidence
Chapter 20.4. When to Believe a Subgroup Analysis
Gordon Guyatt, Peter Wyer, John Ioannidis
Clinical Scenario


Topics Discussed: advanced cardiac life support, cardiac arrest, effects of subgroup analysis, epinephrine, statistics in subgroup analyses, subgroup analysis, vasopressins

Excerpt: "You are the medical director of the emergency medical service in your region. The chair of your resuscitation training committee observes that your protocols for cardiac arrest do not include vasopressin. He points to a study in the New England Journal of Medicine that suggested that vasopressin, relative to epinephrine, saved lives in patients presenting in asystole1 and that its use was supported by an editorial in the same issue.2 He also mentions that the American Heart Association has released an update of their well-known Advanced Cardiac Life Support guidelines3 and observes that they list vasopressin as a valid alternative to epinephrine, at the same time acknowledging that this recommendation is controversial.4..."
Log in to read the full chapter:
Subscriber Log In
Username:
Password:
Forgot your username/password?
Or  
Get full access to JAMAevidence two ways:
Subscribe to JAMAevidence
JAMAevidence is a subscription-
based website dedicated to the learning, teaching, and practicing of evidence-based medicine.
Pay Per View
Timed access to all of JAMAevidence
24 hours for $29.95
48 hours for $49.95
Copyright © American Medical Association. All rights reserved.  |  JAMA  |  McGraw-Hill Global Education Holdings, LLC.
Privacy Notice. Any use is subject to the Terms of Use and Notice. Additional Credits and Copyright Information.
Your IP address is 23.22.212.158